Monoubiquitination by the human Fanconi Anemia core complex clamps FANCI:FANCD2 on DNA in filamentous arrays

  1. Winnie Tan
  2. Sylvie van Twest
  3. Andrew Leis
  4. Rohan Bythell-Douglas
  5. Vincent J Murphy
  6. Michael Sharp
  7. Michael W Parker
  8. Wayne M Crismani
  9. Andrew J Deans  Is a corresponding author
  1. St Vincent's Institute of Medical Research, Australia
  2. University of Melbourne, Australia

Abstract

FANCI:FANCD2 monoubiquitination is a critical event for replication fork stabilization by the Fanconi anemia (FA) DNA repair pathway. It has been proposed that at stalled replication forks, monoubiquitinated-FANCD2 serves to recruit DNA repair proteins that contain ubiquitin-binding motifs. Here we have reconstituted the FA pathway in vitro to study functional consequences of FANCI:FANCD2 monoubiquitination. We report that monoubiquitination does not promote any specific exogenous protein:protein interactions, but instead stabilizes FANCI:FANCD2 heterodimers on dsDNA. This clamping requires monoubiquitination of only the FANCD2 subunit. We further show that purified monoubiquitinated FANCI:FANCD2 forms filament-like arrays on long dsDNA using electron microscopy. Our results reveal how monoubiquitinated FANCI:FANCD2, defective in many cancer types and all cases of FA, is activated upon DNA binding.

Data availability

All data generated or analysed during this study are included in the manuscript and supporting files.

Article and author information

Author details

  1. Winnie Tan

    Genome Stability Unit, St Vincent's Institute of Medical Research, Fitzroy, Australia
    Competing interests
    The authors declare that no competing interests exist.
  2. Sylvie van Twest

    Genome Stability Unit, St Vincent's Institute of Medical Research, Fitzroy, Australia
    Competing interests
    The authors declare that no competing interests exist.
  3. Andrew Leis

    Department of Biochemistry, University of Melbourne, Melbourne, Australia
    Competing interests
    The authors declare that no competing interests exist.
  4. Rohan Bythell-Douglas

    Genome Stability Unit, St Vincent's Institute of Medical Research, Fitzroy, Australia
    Competing interests
    The authors declare that no competing interests exist.
  5. Vincent J Murphy

    Genome Stability Unit, St Vincent's Institute of Medical Research, Fitzroy, Australia
    Competing interests
    The authors declare that no competing interests exist.
  6. Michael Sharp

    Genome Stability Unit, St Vincent's Institute of Medical Research, Fitzroy, Australia
    Competing interests
    The authors declare that no competing interests exist.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0002-1019-3729
  7. Michael W Parker

    Australian Cancer Research Foundation Rational Drug Discovery Centre, St Vincent's Institute of Medical Research, Fitzroy, Australia
    Competing interests
    The authors declare that no competing interests exist.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0002-3101-1138
  8. Wayne M Crismani

    Genome Stability Unit, St Vincent's Institute of Medical Research, Fitzroy, Australia
    Competing interests
    The authors declare that no competing interests exist.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0003-0143-8293
  9. Andrew J Deans

    Genome Stability Unit, St Vincent's Institute of Medical Research, Fitzroy, Australia
    For correspondence
    adeans@svi.edu.au
    Competing interests
    The authors declare that no competing interests exist.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0002-5271-4422

Funding

National Health and Medical Research Council (GNT1123100 and GNT1181110)

  • Andrew J Deans

National Health and Medical Research Council (GNT1156343)

  • Wayne M Crismani

Fanconi Anemia Research Fund

  • Wayne M Crismani
  • Andrew J Deans

Victorian Government's OIS Program

  • Winnie Tan
  • Sylvie van Twest
  • Rohan Bythell-Douglas
  • Vincent J Murphy
  • Michael Sharp
  • Michael W Parker
  • Wayne M Crismani
  • Andrew J Deans

Maddie Riewoldt's Vision

  • Wayne M Crismani
  • Andrew J Deans

Victorian Cancer Agency

  • Andrew J Deans

The funders had no role in study design, data collection and interpretation, or the decision to submit the work for publication.

Reviewing Editor

  1. Wolf-Dietrich Heyer, University of California, Davis, United States

Publication history

  1. Received: December 3, 2019
  2. Accepted: March 12, 2020
  3. Accepted Manuscript published: March 13, 2020 (version 1)
  4. Version of Record published: April 14, 2020 (version 2)

Copyright

© 2020, Tan et al.

This article is distributed under the terms of the Creative Commons Attribution License permitting unrestricted use and redistribution provided that the original author and source are credited.

Metrics

  • 2,754
    Page views
  • 355
    Downloads
  • 34
    Citations

Article citation count generated by polling the highest count across the following sources: Crossref, Scopus, PubMed Central.

Download links

A two-part list of links to download the article, or parts of the article, in various formats.

Downloads (link to download the article as PDF)

Open citations (links to open the citations from this article in various online reference manager services)

Cite this article (links to download the citations from this article in formats compatible with various reference manager tools)

  1. Winnie Tan
  2. Sylvie van Twest
  3. Andrew Leis
  4. Rohan Bythell-Douglas
  5. Vincent J Murphy
  6. Michael Sharp
  7. Michael W Parker
  8. Wayne M Crismani
  9. Andrew J Deans
(2020)
Monoubiquitination by the human Fanconi Anemia core complex clamps FANCI:FANCD2 on DNA in filamentous arrays
eLife 9:e54128.
https://doi.org/10.7554/eLife.54128

Further reading

    1. Cell Biology
    2. Chromosomes and Gene Expression
    Jakub Gemperle et al.
    Tools and Resources

    CRISPR technology has made generation of gene knock-outs widely achievable in cells. However, once inactivated, their re-activation remains difficult, especially in diploid cells. Here, we present DExCon (Doxycycline-mediated endogenous gene Expression Control), DExogron (DExCon combined with auxin-mediated targeted protein degradation), and LUXon (light responsive DExCon) approaches which combine one-step CRISPR-Cas9-mediated targeted knockin of fluorescent proteins with an advanced Tet-inducible TRE3GS promoter. These approaches combine blockade of active gene expression with the ability to re-activate expression on demand, including activation of silenced genes. Systematic control can be exerted using doxycycline or spatiotemporally by light, and we demonstrate functional knock-out/rescue in the closely related Rab11 family of vesicle trafficking regulators. Fluorescent protein knock-in results in bright signals compatible with low-light live microscopy from monoallelic modification, the potential to simultaneously image different alleles of the same gene, and bypasses the need to work with clones. Protein levels are easily tunable to correspond with endogenous expression through cell sorting (DExCon), timing of light illumination (LUXon), or by exposing cells to different levels of auxin (DExogron). Furthermore, our approach allowed us to quantify previously unforeseen differences in vesicle dynamics, transferrin receptor recycling, expression kinetics, and protein stability among highly similar endogenous Rab11 family members and their colocalization in triple knock-in ovarian cancer cell lines.

    1. Chromosomes and Gene Expression
    Sarah Lensch et al.
    Research Article

    In mammalian cells genes that are in close proximity can be transcriptionally coupled: silencing or activating one gene can affect its neighbors. Understanding these dynamics is important for natural processes, such as heterochromatin spreading during development and aging, and when designing synthetic gene regulation circuits. Here, we systematically dissect this process in single cells by recruiting and releasing repressive chromatin regulators at dual-gene synthetic reporters, and measuring how fast gene silencing and reactivation spread as a function of intergenic distance and configuration of insulator elements. We find that silencing by KRAB, associated with histone methylation, spreads between two genes within hours, with a time delay that increases with distance. This fast KRAB-mediated spreading is not blocked by the classical cHS4 insulators. Silencing by histone deacetylase HDAC4 of the upstream gene can also facilitate background silencing of the downstream gene by PRC2, but with a days-long delay that does not change with distance. This slower silencing can sometimes be stopped by insulators. Gene reactivation of neighboring genes is also coupled, with strong promoters and insulators determining the order of reactivation. Our data can be described by a model of multi-gene regulation that builds upon previous knowledge of heterochromatin spreading, where both gene silencing and gene reactivation can act at a distance, allowing for coordinated dynamics via chromatin regulator recruitment.